© 1988 Oxford University Press
research-article |
Rapid growth of preneoplastic lesions in hepatocarcinogen-Sensitive C3H/HeJ male mice relative to C57BL/6J male mice
McArdle Laboratory for Cancer Research, University of Wisconsin Madison, WI 53706, USA
We have previously shown that C3H/HeJ male mice are {small tilde} 20-fold more susceptible to the induction of liver tumors by N-ethyl-N-nitrosourea (ENU) than are C57BL/6J male mice and that this difference in sensitivity is largely determined by a single genetic locus (Hcs, hepatocarcinogen sensitivity). In order to determine whether the Hcs locus affects initiation or promotion of hepatocarcinogenesis, we studied the development of putatively preneoplastic hepatic lesions that are deficient in glucose-6-phosphatase (G6Pase) in mice treated at 12 days of age with ENU. In ENU-treated male mice of both strains, the number and size of G6Pase-deficient hepatic foci increased over time between 12 and 24 weeks of age. However, the rate of growth of the lesions was 1.7 times faster for C3H/HeJ male mice (volume doubling time 2.0 ± 0.1 weeks) than for C57BL/6J mice (3.4 ± 0.4 weeks). Although the number and size of G6Pase-deficient foci induced by ENU treatment of female C3H/HeJ and C57BL/6J mice were smaller than for foci in similarly treated male mice, there was no significant difference between the growth rates of the foci in female C3H/HeJ and C57BL/6J mice. Thus, the phenotypic effect of the Hcs locus appears to be dependent on promotion of liver tumor induction by the male hormonal environment. In agreement with studies on the growth rate of the foci in male mice, the [3H]thymidine labeling index of G6Pase-deficient hepatocytes in C3H/HeJ males (12%) was 1.5-fold higher than in C57BL/6J male mice (8.0%) at 20 weeks and 1.2-fold higher at 28 weeks (11% versus 9.5%). The labeling index of histochemically normal hepato cytes in C3H/HeJ male mice (0.38%) was 2.6-fold higher than in C57BL/6J mice (0.15%) The Hcs locus may affect the promotion phase of hepatocarcinogenesis in male mice by increasing the proliferative rate of both normal and preneoplastic hepatocytes.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. E.-M. Peychal, A. Bilger, H. C. Pitot, and N. R. Drinkwater Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17 Carcinogenesis, May 1, 2009; 30(5): 879 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. P. Pogribny, V. P. Tryndyak, L. Muskhelishvili, I. Rusyn, and S. A. Ross Methyl Deficiency, Alterations in Global Histone Modifications, and Carcinogenesis J. Nutr., January 1, 2007; 137(1): 216S - 222S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Bursch, M. Chabicovsky, U. Wastl, B. Grasl-Kraupp, K. Bukowska, H. Taper, and R. Schulte-Hermann Apoptosis in Stages of Mouse Hepatocarcinogenesis: Failure to Counterbalance Cell Proliferation and to Account for Strain Differences in Tumor Susceptibility Toxicol. Sci., May 1, 2005; 85(1): 515 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bilger, L. M. Bennett, R. A. Carabeo, T. A. Chiaverotti, C. Dvorak, K. M. Liss, S. A. Schadewald, H. C. Pitot, and N. R. Drinkwater A Potent Modifier of Liver Cancer Risk on Distal Mouse Chromosome 1: Linkage Analysis and Characterization of Congenic Lines Genetics, June 1, 2004; 167(2): 859 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.R. Maronpot, G. Flake, and A. J. Huff Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention Toxicol Pathol, January 1, 2004; 32(1_suppl): 40 - 48. [Abstract] [PDF]
|
|
|
|
|
|
K. Takahashi, G. E. Dinse, J. F. Foley, J. F. Hardisty, and R. R. Maronpot Comparative Prevalence, Multiplicity, and Progression of Spontaneous and Vinyl Carbamate-Induced Liver Lesions in Five Strains of Male Mice Toxicol Pathol, August 1, 2002; 30(5): 599 - 605. [Abstract] [PDF]
|
|
|
|
|
|
R. E. Watson and J. I. Goodman Effects of Phenobarbital on DNA Methylation in GC-Rich Regions of Hepatic DNA from Mice That Exhibit Different Levels of Susceptibility to Liver Tumorigenesis Toxicol. Sci., July 1, 2002; 68(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takahashi, Y. Nakatsuru, S. Zhang, Y. Shimizu, H. Kume, K. Tanaka, F. Ide, and T. Ishikawa Enhanced spontaneous and aflatoxin-induced liver tumorigenesis in xeroderma pigmentosum group A gene-deficient mice Carcinogenesis, April 1, 2002; 23(4): 627 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-Q. Zhou, D. Manguino, K. Kewitt, G. W. Intano, C. A. McMahan, D. C. Herbert, M. Hanes, R. Reddick, Y. Ikeno, and C. A. Walter Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase PNAS, October 12, 2001; (2001) 221232998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Moennikes, A. Buchmann, T. Ott, K. Willecke1, and M. Schwarz2 The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains Carcinogenesis, July 1, 1999; 20(7): 1379 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Jin, J. Vacher, and M. H. Feuerman alpha -Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration PNAS, July 21, 1998; 95(15): 8767 - 8772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, J. Ishmael, J. Odum, J.D. Tugwood, S. Kettle, and I.F.H. Purchase Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis Human and Experimental Toxicology, January 1, 1994; 13(2_suppl): S1 - S117. [PDF]
|
|
|
|
|
|
Z.-Q. Zhou, D. Manguino, K. Kewitt, G. W. Intano, C. A. McMahan, D. C. Herbert, M. Hanes, R. Reddick, Y. Ikeno, and C. A. Walter Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase PNAS, October 23, 2001; 98(22): 12566 - 12571. [Abstract] [Full Text] [PDF]
|
|